Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.102M
March 31, 2026 -1.688M
December 31, 2025 -3.856M
September 30, 2025 -15.27M
June 30, 2025 -5.65M
March 31, 2025 -2.817M
December 31, 2024 -3.884M
September 30, 2024 -197.17M
June 30, 2024 -7.381M
March 31, 2024 -1.732M
December 31, 2023 -2.756M
September 30, 2023 -2.785M
June 30, 2023 -2.77M
March 31, 2023 -2.177M
December 31, 2022 -2.964M
September 30, 2022 33.40M
June 30, 2022 -6.168M
March 31, 2022 -22.98M
December 31, 2021 -97.23M
September 30, 2021 -0.965M
June 30, 2021 -1.812M
March 31, 2021 -1.449M
December 31, 2020 -1.309M
September 30, 2020 -0.828M
June 30, 2020 -1.117M
Date Value
March 31, 2020 -1.007M
December 31, 2019 -1.393M
September 30, 2019 -1.562M
June 30, 2019 -1.431M
March 31, 2019 -1.388M
December 31, 2018 -0.907M
September 30, 2018 -1.521M
June 30, 2018 -1.469M
March 31, 2018 -78.43M
December 31, 2017 -3.501M
September 30, 2017 -2.409M
June 30, 2017 -3.007M
March 31, 2017 -1.458M
December 31, 2016 -1.206M
September 30, 2016 -1.717M
June 30, 2016 -2.758M
March 31, 2016 -1.598M
December 31, 2015 -3.296M
September 30, 2015 -2.542M
June 30, 2015 -1.939M
March 31, 2015 -8.491M
December 31, 2014 -2.468M
September 30, 2014 -3.601M
June 30, 2014 -5.878M
March 31, 2014 -1.377M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -129.05M
Abbott Laboratories --
AngioDynamics, Inc. -3.148M
Alphatec Holdings, Inc. -22.72M
AtriCure, Inc. -3.766M